University of Texas: COVID-19 Convalescent Plasma Therapy is Safe, With 76% of Patients Improving
June 03, 2020
June 03, 2020
AUSTIN, Texas, June 3 -- The University of Texas issued the following news release:
The country's first peer-reviewed study of a COVID-19 treatment that transfuses blood plasma from recovered patients into critically ill patients shows 19 out of 25 patients improving, including 11 discharged from the hospital.
On March 28, Houston Methodist Hospital became the first academic medical center in the U.S. to transfuse plasma from recovered COVID-19 patients into two critica . . .
The country's first peer-reviewed study of a COVID-19 treatment that transfuses blood plasma from recovered patients into critically ill patients shows 19 out of 25 patients improving, including 11 discharged from the hospital.
On March 28, Houston Methodist Hospital became the first academic medical center in the U.S. to transfuse plasma from recovered COVID-19 patients into two critica . . .